Brinker Capital Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.41M | Buy |
4,309
+452
| +12% | +$147K | 0.01% | 987 |
|
2025
Q1 | $1.04M | Buy |
3,857
+113
| +3% | +$30.5K | 0.01% | 1062 |
|
2024
Q4 | $881K | Buy |
3,744
+203
| +6% | +$47.8K | 0.01% | 1122 |
|
2024
Q3 | $974K | Buy |
3,541
+457
| +15% | +$126K | 0.01% | 1049 |
|
2024
Q2 | $749K | Buy |
3,084
+939
| +44% | +$228K | 0.01% | 1114 |
|
2024
Q1 | $321K | Sell |
2,145
-384
| -15% | -$57.4K | ﹤0.01% | 1436 |
|
2023
Q4 | $498K | Sell |
2,529
-56
| -2% | -$11K | 0.01% | 1212 |
|
2023
Q3 | $458K | Buy |
2,585
+229
| +10% | +$40.6K | 0.01% | 1232 |
|
2023
Q2 | $447K | Sell |
2,356
-128
| -5% | -$24.3K | ﹤0.01% | 1252 |
|
2023
Q1 | $498K | Sell |
2,484
-28
| -1% | -$5.61K | 0.01% | 1142 |
|
2022
Q4 | $597K | Sell |
2,512
-141
| -5% | -$33.5K | 0.01% | 918 |
|
2022
Q3 | $531K | Buy |
2,653
+160
| +6% | +$32K | 0.01% | 928 |
|
2022
Q2 | $364K | Sell |
2,493
-281
| -10% | -$41K | 0.01% | 1091 |
|
2022
Q1 | $453K | Sell |
2,774
-48
| -2% | -$7.84K | 0.01% | 1084 |
|
2021
Q4 | $479K | Buy |
2,822
+349
| +14% | +$59.2K | 0.01% | 1067 |
|
2021
Q3 | $419K | Hold |
2,473
| – | – | 0.01% | 1031 |
|
2021
Q2 | $419K | Buy |
2,473
+558
| +29% | +$94.5K | 0.01% | 1090 |
|
2021
Q1 | $270K | Buy |
+1,915
| New | +$270K | ﹤0.01% | 1079 |
|
2020
Q1 | – | Sell |
-600
| Closed | -$69K | – | 318 |
|
2019
Q4 | $69K | Hold |
600
| – | – | ﹤0.01% | 389 |
|
2019
Q3 | $48K | Hold |
600
| – | – | ﹤0.01% | 433 |
|
2019
Q2 | $44K | Hold |
600
| – | – | ﹤0.01% | 604 |
|
2019
Q1 | $56K | Sell |
600
-540
| -47% | -$50.4K | ﹤0.01% | 455 |
|
2018
Q4 | $83K | Hold |
1,140
| – | – | ﹤0.01% | 357 |
|
2018
Q3 | $100K | Hold |
1,140
| – | – | ﹤0.01% | 323 |
|
2018
Q2 | $112K | Hold |
1,140
| – | – | ﹤0.01% | 326 |
|
2018
Q1 | $136K | Buy |
+1,140
| New | +$136K | ﹤0.01% | 302 |
|
2015
Q3 | – | Sell |
-37
| Closed | -$4K | – | 453 |
|
2015
Q2 | $4K | Buy |
+37
| New | +$4K | ﹤0.01% | 394 |
|